Navigation Links
Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 Clinical Trials
Date:9/25/2008

HREF="http://studio-5.financialcontent.com/prnews?Page=Quote&Ticker=NTII" onClick="var s=s_gi(s_account); var hd1 = document.getElementById('headline'); s.tl(this,'o',getLinkName('Company Sanpshot'));" >NTII) is a biopharmaceutical company focused on developing novel, first-in-class agents for central nervous system conditions and other serious unmet medical needs. The Company's most advanced product candidate, Viprinex(TM) (ancrod), is in Phase 3 clinical testing as a novel investigational drug for the treatment of acute ischemic stroke. Viprinex has multiple mechanisms of action and is specifically designed to extend the time period that patients can be treated after the onset of a stroke. Acute ischemic stroke is one of the most prevalent, debilitating and costly diseases in the world for which there are few acceptable treatment options. NTI also has early-stage development programs for Alzheimer's and Huntington's diseases and rights to receive payments on an approved drug for Alzheimer's disease and an investigational drug in Phase 3 trials for brain swelling.

NOTE: Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties, including uncertainties regarding the development of Viprinex for acute ischemic stroke, delays or other problems with our clinical trials, the outcome of the interim analysis, the time and costs for obtaining approval for Viprinex, and levels of future expenditures and capital resources needed to fund operations, as well as other risks detailed from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K, as updated periodically in Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Actual results may differ materially from those projected. These forward-looking statements represent our judgment as of the date of the release and we undertake no obligati
'/>"/>

SOURCE Neurobiological Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014 Decision Resources Group finds that, for ... ( France , Germany ... and the United Kingdom ... once-daily long-acting beta2 agonist/inhaled corticosteroid (LABA/ICS) fixed-dose combination (FDC), ... as a first-line LABA/ICS FDC in the treatment of ...
(Date:7/24/2014)... -- "North America Orthopedic Braces and Supports Market Outlook ... America Orthopedic Braces and Supports market. The report provides ... units) and average price data (in US dollars), within ... , Ankle Braces and Supports , Spinal ... Supports. Photo - http://photos.prnewswire.com/prnh/20140723/129806 ...
(Date:7/24/2014)... BOSTON , July 24, 2014 Boston ... on Tomorrow (#PedInno14), will feature an "Innovation Tank" ... innovators an opportunity to pitch their business or product ... of funding and feedback on how to accelerate the ... competition, occurring the morning of Friday, October 31, will ...
Breaking Medicine Technology:Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 2Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 5Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 2Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 3
... /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: ... diagnostic ("IVD") company, announced its unaudited financial results for ... FY2010") today. 3Q FY2010 ... 2009December 31, 2010December 31, ...
... Zimmer Holdings, Inc. (NYSE: ZMH ; SIX: ... launch of the PathFinder NXT™ System at the ... San Diego, CA.  The PathFinder NXT System builds ... PathFinder Minimally Invasive Pedicle Screw System to ...
Cached Medicine Technology:China Medical Technologies Reports Third Fiscal Quarter Financial Results 2China Medical Technologies Reports Third Fiscal Quarter Financial Results 3China Medical Technologies Reports Third Fiscal Quarter Financial Results 4China Medical Technologies Reports Third Fiscal Quarter Financial Results 5China Medical Technologies Reports Third Fiscal Quarter Financial Results 6China Medical Technologies Reports Third Fiscal Quarter Financial Results 7China Medical Technologies Reports Third Fiscal Quarter Financial Results 8China Medical Technologies Reports Third Fiscal Quarter Financial Results 9China Medical Technologies Reports Third Fiscal Quarter Financial Results 10China Medical Technologies Reports Third Fiscal Quarter Financial Results 11China Medical Technologies Reports Third Fiscal Quarter Financial Results 12China Medical Technologies Reports Third Fiscal Quarter Financial Results 13China Medical Technologies Reports Third Fiscal Quarter Financial Results 14China Medical Technologies Reports Third Fiscal Quarter Financial Results 15China Medical Technologies Reports Third Fiscal Quarter Financial Results 16China Medical Technologies Reports Third Fiscal Quarter Financial Results 17China Medical Technologies Reports Third Fiscal Quarter Financial Results 18China Medical Technologies Reports Third Fiscal Quarter Financial Results 19China Medical Technologies Reports Third Fiscal Quarter Financial Results 20China Medical Technologies Reports Third Fiscal Quarter Financial Results 21China Medical Technologies Reports Third Fiscal Quarter Financial Results 22Zimmer Launches PathFinder NXT™ Minimally Invasive Pedicle Screw System 2Zimmer Launches PathFinder NXT™ Minimally Invasive Pedicle Screw System 3
(Date:7/24/2014)... July 25, 2014 The report, ... the CDN market into various sub-segments with an ... identifies the drivers and restraints for this market ... Browse 93 market data tables and 36 figures ... “Content Delivery Networks (CDN) Market” at http://www.marketsandmarkets.com/Market-Reports/content-delivery-networks-cdn-market-657.html ...
(Date:7/24/2014)... HealthDay Reporter THURSDAY, July 24, 2014 (HealthDay ... dead wrong, according to a small study that asked boys what ... boys between the ages of 14 and 16, researchers found that ... closeness and trust. Very few boasted about sexual conquests or saw ... girl. "In our culture, we have lots of assumptions about ...
(Date:7/24/2014)... RI (PRWEB) July 24, 2014 Pools and ... But the water can be dangerous, especially for small children, ... promote water safety. , According to the Centers for Disease ... 4 are most at risk for water-related injuries and deaths. ... children safe around water, so Amica is offering the following ...
(Date:7/24/2014)... (HealthDay News) -- Drinking caffeine may worsen the hot ... women as they go through menopause, new survey data ... suggests that limiting caffeine intake may be useful for ... night sweats," said researcher Dr. Stephanie Faubion, director of ... Rochester, Minn. But caffeine -- a stimulant found ...
(Date:7/24/2014)... Horizon BCBSNJ’s second annual “Back to ... a rent-free week in a beautiful Lavallette shore house, ... miss your chance to win a week’s vacation at ... New Jersey residents, 25 or older.* Residents can enter ... . , “A family vacation at the Jersey ...
Breaking Medicine News(10 mins):Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 3Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 2Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 3Health News:Keep Kids Safe in the Water with 5 Tips from Amica 2Health News:Is Coffee Aggravating Your Hot Flashes? 2Health News:(Beach) Sands of Time Running out to Enter Horizon Blue Cross Blue Shield of New Jersey’s 2014 “Back to the Boardwalk” Sweepstakes 2
... in year-end KLAS survey, PITTSBURGH, Jan. 10 ... by major healthcare providers who,use automated patient flow ... The ranking was listed in the KLAS 2007 ... thousands of healthcare professionals of,health information technology vendors ...
... Clients Suffering from Smoking-Related Illnesses Fight Back against Big ... ... trial attorney, Willie,Gary, along with partners, CK Hoffler, Donald Watson and ... Watson and,Sperando, P.L. announced today that the firm will be representing ...
... climate change was a leading topic of interest for ... two stories that portrayed significantly different messages about the ... Stories in 2007 were identified by monitoring Web site ... highest total number of visits between January and December ...
... at The University of Texas Health Science Center at ... human saliva to provide an early, non-invasive diagnosis of ... Jan. 10, 2008 issue of the journal "Cancer Investigation." ... cancer produces a change in the normal type and ...
... care quality evaluator determines programs improve ... ... Health,Solutions, Inc., (NYSE: MHS ) today announced that it has ... member engagement programs that improve pharmacy care and,prescription drug safety. The ...
... discovery company builds strong financial and clinical foundation, in preparation for ... ... for diabetes, EMERYVILLE, Calif., Jan. 10 ... in its drive to,release Tethys Diabetes PreDxTM, a multi-biomarker technology that ...
Cached Medicine News:Health News:KLAS Ranks TeleTracking Bed Management Suite No. 1 2Health News:Famed Attorney Willie Gary Files $10.6 Billion in Lawsuits against Big Tobacco Companies on Behalf of Florida Smokers and their Families 2Health News:Climate change, gender differences, health among EurekAlert! 10 Most Popular Stories in 2007 2Health News:Climate change, gender differences, health among EurekAlert! 10 Most Popular Stories in 2007 3Health News:Climate change, gender differences, health among EurekAlert! 10 Most Popular Stories in 2007 4Health News:Climate change, gender differences, health among EurekAlert! 10 Most Popular Stories in 2007 5Health News:Climate change, gender differences, health among EurekAlert! 10 Most Popular Stories in 2007 6Health News:UT Health Science Center researchers decoding saliva to detect breast cancer 2Health News:UT Health Science Center researchers decoding saliva to detect breast cancer 3Health News:Medco's Specialized Pharmacists, Safety Programs Gain Therapy Management Accreditation 2Health News:Medco's Specialized Pharmacists, Safety Programs Gain Therapy Management Accreditation 3Health News:Medco's Specialized Pharmacists, Safety Programs Gain Therapy Management Accreditation 4Health News:Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory 2Health News:Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory 3
Single Use Loading Units with Titanium Staples for use with Powered MULTIFIRE ENDO GIA™ 60 (15 mm Single Use Stapler with Titanium Staples)....
Providing maximum versatility and maneuverability, the Articulator 35 is the only stapler for use in endoscopic and open procures that provides greater access to targeted structures with limited oper...
Improved Access in Open Procedures with Compact Endoscopic Linear Cutters., ,Staplers may be reloaded seven times for a total of eight firings. Different cartridges of the same size can be interchan...
... ETS45 and ETS-FLEX45 Endoscopic Linear ... and cut line. The 34cm ... suitable for many minimally invasive ... intended for transection, resection, and/or ...
Medicine Products: